Esperion Therapeutics Inc (NASDAQ:ESPR) price closed higher on Tuesday, March 18, and jumping 2.60% above its previous close. A look at the daily price movement shows that the last close reads $1.54, with intraday deals fluctuated between $1.47 and $1.59. The company’s 5Y monthly beta
Esperion Therapeutics Inc (NASDAQ:ESPR) concluded the trading at $1.52 on Wednesday, March 12 with a fall of -1.94% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.55 and 5Y monthly beta
Esperion Therapeutics Inc (NASDAQ:ESPR) traded at $1.61 at last check on current trade day and made a downward move of -5.03% on its previous day’s price. Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 54.97M, with a
Esperion Therapeutics Inc (NASDAQ:ESPR) shares, rose in value, with the stock price down by -6.78% to the previous day’s close as strong demand from buyers drove the stock to $1.65. Actively observing the price movement in the last trading, the stock closed the session at
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
